Market Watch Highlights: Syndax Pharmaceuticals Inc (SNDX) Ends on an Downturn Note at 21.99

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Syndax Pharmaceuticals Inc’s stock clocked out at $21.99, down -10.21% from its previous closing price of $24.49. In other words, the price has decreased by -$10.21 from its previous closing price. On the day, 3.16 million shares were traded. SNDX stock price reached its highest trading level at $22.05 during the session, while it also had its lowest trading level at $20.45.

Ratios:

To gain a deeper understanding of SNDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.93 and its Current Ratio is at 8.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $37.

On January 31, 2024, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform and also lowered its target price recommendation from $36 to $23.

On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.Mizuho initiated its Buy rating on December 22, 2023, with a $45 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.

Morrison Briggs sold 52,855 shares of SNDX for $965,402 on Aug 09 ’23. The Director now owns 17,836 shares after completing the transaction at $18.27 per share. On Aug 02 ’23, another insider, Meury William, who serves as the Director of the company, sold 83,000 shares for $20.46 each. As a result, the insider received 1,697,810 and left with 48,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1868866432 and an Enterprise Value of 1427092480.

Stock Price History:

Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is 4.39%, while the 200-Day Moving Average is calculated to be 9.79%.

Shares Statistics:

It appears that SNDX traded 1.05M shares on average per day over the past three months and 1105620 shares per day over the past ten days. A total of 84.83M shares are outstanding, with a floating share count of 80.06M. Insiders hold about 5.80% of the company’s shares, while institutions hold 101.61% stake in the company. Shares short for SNDX as of 1721001600 were 8522704 with a Short Ratio of 8.08, compared to 1718323200 on 9916846. Therefore, it implies a Short% of Shares Outstanding of 8522704 and a Short% of Float of 10.11.

Most Popular